Literature DB >> 19653042

Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.

Dake Chu1, Jianyong Zheng, Weizhong Wang, Qingchuan Zhao, Yunming Li, Jipeng Li, Huahong Xie, Hongwei Zhang, Guanglong Dong, Chunsheng Xu, Mengbin Li, Dongli Chen, Gang Ji.   

Abstract

BACKGROUND: The significance of Notch2 expression in colorectal cancer (CRC) has not been clearly investigated. We investigated the expression of Notch2 and its relationship with differentiation status and tumor stage by studying clinical CRC specimens with matched adjacent normal tissues and normal control colorectal specimens.
METHODS: Immunohistochemistry, real-time polymerase chain reaction, and Western blot analysis were performed to assess the expression of Notch2 in clinical CRC specimens. Also, Notch2 levels in an induced differentiation model of CRC cell lines were investigated.
RESULTS: It was found that Notch2 expression was decreased in cancer tissues compared with adjacent normal tissue and normal control tissues. Also, a tendency for decreased expression was observed when going from well to poorly differentiated carcinomas, as well as going from tumor, node, metastasis system stage I to stage IV. With the differentiation of colon cancer cells, the expression of Notch2 increased. To support this observation, colon cancer cell lines HT29 and SW620 were induced to differentiate in culture, and expression of Notch2 was investigated. A clear increase expression of Notch2 was observed.
CONCLUSIONS: Notch2 expression correlated closely with CRC and may play a role in tumor inhibition in colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653042     DOI: 10.1245/s10434-009-0655-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

1.  A pilot study evaluating genetic alterations that drive tobacco- and betel quid-associated oral cancer in Northeast India.

Authors:  Dhirendra Singh Yadav; Indranil Chattopadhyay; Anand Verma; Thoudam Regina Devi; L C Singh; Jagannath Dev Sharma; Amal Ch Kataki; Sunita Saxena; Sujala Kapur
Journal:  Tumour Biol       Date:  2014-06-19

2.  Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma.

Authors:  Jing Qu; Min Song; Jian Xie; Xiao-Yu Huang; Xiao-Meng Hu; Rui-Huan Gan; Yong Zhao; Li-Song Lin; Jiang Chen; Xu Lin; Da-Li Zheng; You-Guang Lu
Journal:  Mol Cell Biochem       Date:  2015-10-01       Impact factor: 3.396

3.  Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.

Authors:  José María Sayagués; Celia Fontanillo; María del Mar Abad; María González-González; María Eugenia Sarasquete; Maria del Carmen Chillon; Eva Garcia; Oscar Bengoechea; Emilio Fonseca; Marcos Gonzalez-Diaz; Javier De las Rivas; Luís Muñoz-Bellvis; Alberto Orfao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

4.  NOTCH2 expression is decreased in epithelial ovarian cancer and is related to the tumor histological subtype.

Authors:  Vijaya Galic; Carrie J Shawber; Claire Reeves; Monjri Shah; Aino Murtomaki; Jason Wright; Thomas Herzog; Guo Xia Tong; Jan Kitajewski
Journal:  Pathol Discov       Date:  2013-08-16

Review 5.  Role of Notch signalling pathway in cancer and its association with DNA methylation.

Authors:  Madhuri G S Aithal; Narayanappa Rajeswari
Journal:  J Genet       Date:  2013-12       Impact factor: 1.166

6.  The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells.

Authors:  Jonas Ungerbäck; Nils Elander; John Grünberg; Mikael Sigvardsson; Peter Söderkvist
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

7.  Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study.

Authors:  Lukas Bauer; Agnes Takacs; Julia Slotta-Huspenina; Rupert Langer; Karen Becker; Alexander Novotny; Katja Ott; Axel Walch; Alexander Hapfelmeier; Gisela Keller
Journal:  Front Oncol       Date:  2015-04-22       Impact factor: 6.244

8.  Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing.

Authors:  Yan'an Wu; Xuetao Wang; Fangbo Wu; Ruolei Huang; Fangqin Xue; Guantao Liang; Min Tao; Pengwei Cai; Yi Huang
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

9.  Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling.

Authors:  Heiying Jin; Wei Gong; Chunxia Zhang; Shuiming Wang
Journal:  Onco Targets Ther       Date:  2013-03-08       Impact factor: 4.147

10.  Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer.

Authors:  Maria N Timofeeva; Ben Kinnersley; Susan M Farrington; Nicola Whiffin; Claire Palles; Victoria Svinti; Amy Lloyd; Maggie Gorman; Li-Yin Ooi; Fay Hosking; Ella Barclay; Lina Zgaga; Sara Dobbins; Lynn Martin; Evropi Theodoratou; Peter Broderick; Albert Tenesa; Claire Smillie; Graeme Grimes; Caroline Hayward; Archie Campbell; David Porteous; Ian J Deary; Sarah E Harris; Emma L Northwood; Jennifer H Barrett; Gillian Smith; Roland Wolf; David Forman; Hans Morreau; Dina Ruano; Carli Tops; Juul Wijnen; Melanie Schrumpf; Arnoud Boot; Hans F A Vasen; Frederik J Hes; Tom van Wezel; Andre Franke; Wolgang Lieb; Clemens Schafmayer; Jochen Hampe; Stephan Buch; Peter Propping; Kari Hemminki; Asta Försti; Helga Westers; Robert Hofstra; Manuela Pinheiro; Carla Pinto; Manuel Teixeira; Clara Ruiz-Ponte; Ceres Fernández-Rozadilla; Angel Carracedo; Antoni Castells; Sergi Castellví-Bel; Harry Campbell; D Timothy Bishop; Ian P M Tomlinson; Malcolm G Dunlop; Richard S Houlston
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.